What is the human papillomavirus (HPV) vaccine (Gardasil 9) and when should it be administered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

HPV Vaccine Overview and Timing

The HPV vaccine (Gardasil 9) is a prophylactic vaccine that prevents infection from nine types of human papillomavirus (HPV 6,11,16,18,31,33,45,52, and 58), and should be routinely administered at age 11 or 12 years, though it can be started as early as age 9 years. 1

What the HPV Vaccine Protects Against

Gardasil 9 prevents HPV-related diseases that significantly impact both morbidity and mortality:

In females (ages 9-26):

  • Cervical cancer
  • Vulvar and vaginal cancers
  • Anal cancer
  • Precancerous cervical, vulvar, vaginal, and anal lesions
  • Genital warts 2

In males (ages 9-26):

  • Anal cancer
  • Precancerous anal lesions
  • Genital warts 2

The vaccine targets the HPV types responsible for approximately 90% of cervical cancers and most other HPV-associated malignancies. HPV types 16 and 18 alone cause the majority of HPV-associated cancers, while types 6 and 11 cause most genital warts. 1

When to Administer: Age-Based Dosing Schedule

Routine Vaccination (Ages 11-12 years)

ACIP routinely recommends HPV vaccination at age 11 or 12 years, with the option to start as early as age 9 years. 1 This timing is critical because vaccination is most effective before any HPV exposure through sexual activity. 3

Dosing Schedules by Age

Ages 9-14 years: 2-dose regimen 2

  • Dose 1: Initial vaccination
  • Dose 2: Given 6-12 months after the first dose
  • Important caveat: If the second dose is given earlier than 5 months after the first dose, a third dose must be administered at least 4 months after the second dose 2

Ages 15-26 years: 3-dose regimen 2

  • Dose 1: Initial vaccination
  • Dose 2: 2 months after the first dose
  • Dose 3: 6 months after the first dose

Catch-Up Vaccination

All persons through age 26 years who have not been adequately vaccinated should receive catch-up HPV vaccination. 1 This represents a 2019 harmonization of recommendations that previously had different age cutoffs for males and females.

Ages 27-45 Years: Shared Clinical Decision-Making

For adults aged 27-45 years, ACIP does not recommend routine catch-up vaccination for all individuals. However, shared clinical decision-making is recommended for some unvaccinated persons in this age range who may be at risk for new HPV infection. 1, 3

Consider vaccination in this age group for patients who:

  • Have new sexual partners
  • Are at ongoing risk for HPV acquisition
  • Have not been previously exposed to vaccine-type HPV

The FDA expanded approval for Gardasil 9 to age 45 in 2018, but the benefit decreases with age as most sexually active adults have already been exposed to HPV. 1

Critical Clinical Considerations

What the Vaccine Does NOT Do

  • Does not eliminate the need for cervical cancer screening - women must continue routine screening 2
  • Does not treat existing HPV infections 2
  • Does not protect against HPV types to which someone has already been exposed 2
  • Does not protect against non-vaccine HPV types or other sexually transmitted infections 2

Administration Details

  • Given as an intramuscular injection, typically in the deltoid muscle 2
  • Observe patients for 15 minutes after administration due to syncope risk - fainting can occur and may result in falls with injury 2
  • Shake vial well before use to maintain suspension 2

Contraindications

Do not administer to anyone with:

  • Severe allergic reaction to a previous dose of Gardasil 9 or Gardasil
  • Severe yeast allergy
  • Allergy to amorphous aluminum hydroxyphosphate sulfate or polysorbate 80 2

Special Populations

  • Pregnancy: Not recommended during pregnancy, though inadvertent exposure does not appear to increase risk of major birth defects or miscarriage 4
  • Immunocompromised persons (including HIV): Recommended through age 26 if not previously vaccinated 5
  • Men who have sex with men: Recommended through age 26 if not previously vaccinated 5

Common Pitfall to Avoid

The most significant missed opportunity is failing to vaccinate at the routine age of 11-12 years. Vaccination rates in the United States remain unacceptably low compared to other adolescent vaccines. 6 Every clinical encounter with an eligible patient—including visits for abnormal Pap smears—represents an opportunity to discuss and administer the HPV vaccine. 7

References

Related Questions

Should a 19‑year‑old female receive the 9‑valent human papillomavirus (HPV) vaccine (Gardasil 9) and what is the recommended dosing schedule?
What is the recommended HPV vaccine dosing schedule for different age groups?
Is the 9‑valent human papillomavirus vaccine (Gardasil 9) recommended for a 22‑year‑old female with a prior low‑grade squamous intraepithelial lesion?
Can a 37-year-old patient with human papillomavirus type 13 infection receive the 9-valent human papillomavirus vaccine (Gardasil 9) and what is the recommended dosing schedule?
Should a person who completed the Gardasil (quadrivalent human papillomavirus) vaccine series as a teenager receive Gardasil 9 (nonavalent human papillomavirus) vaccine?
How should a rectal lesion be managed when biopsy shows only a tubulovillous adenoma but MRI indicates extension into the internal sphincter and abutment of the external sphincter?
Is mitral regurgitation a recognized complication of dengue infection?
What type of ocular burn does engine coolant cause when it contacts the cornea?
What does a urine microalbumin result of less than 0.7 mg/dL indicate?
In a 9-year-old child presenting with dysuria, hematuria, and fever, what is the most likely diagnosis?
In a 63-year-old man with chronic neck pain who fell on his right side and now has mid‑thoracic rhomboid pain, and who is currently taking a muscle relaxant, oxycodone, gabapentin, and celecoxib (Celebrex), what evaluation and management should be recommended?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.